DiscoverNewsRamp Science, Exploration and Discovery PodcastAdvancements in Mental Health Treatment and Mineral Exploration Efforts
Advancements in Mental Health Treatment and Mineral Exploration Efforts

Advancements in Mental Health Treatment and Mineral Exploration Efforts

Update: 2024-07-30
Share

Description

Today's episode covers the latest advancements in mental health treatment by MIRA Pharmaceuticals (NASDAQ: MIRA), with promising preclinical trial results for compounds MIRA-55 and Ketamir-2. MIRA-55 offers therapeutic benefits without side effects like increased appetite or paranoia, while Ketamir-2 targets treatment-resistant depression. With a focus on patient care, MIRA aims to improve access and affordability, potentially changing the standard of care for neurological and neuropsychiatric disorders. In other news, Doubleview Gold Corp has resumed drilling at the Hat Project in Northern British Columbia, utilizing technical and statistical models to improve grade and explore mineralization trends for a future Mineral Resource Estimate.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Advancements in Mental Health Treatment and Mineral Exploration Efforts

Advancements in Mental Health Treatment and Mineral Exploration Efforts

NewsRamp